ADVERTISEMENT
Manila Bulletin devider Philippines devider National devider 2 DOST-PCHRD researchers receive Eye Health Heroes Award

2 DOST-PCHRD researchers receive Eye Health Heroes Award

Published Dec 5, 2021 11:15 am

The International Agency for the Prevention of Blindness (IAPB) conferred the Eye Health Heroes Award to two researchers of the Philippine Council for Health Research and Development of the Department of Science and Technology (DOST-PCHRD).

(Photo by Soroush Karimi on Unsplash)

As the premier eye health body, the 46-year-old IAPB groups more than 150 organisations in over 100 countries “working together for a world where everyone has universal access to eye care.”

“Two research assistants from the DOST-PCHRD-supported project “UK-Philippines Remote Retinal Evaluation Collaboration in Health: Diabetic Retinopathy” or REACH-DR are among this year’s awardees of the International Agency for the Prevention of Blindness’ Eye Health Heroes,” DOST Secretary Fortunato “Boy” T. de la Peña announced on DOSTv Facebook page on Friday, Dec. 3.

The DOST chief said the recipients of the IAPB award were Dr. Recivall Salongcay and Lizzie Anne Aquino who are involved in the REACH-DR project.

The REACH-DR is a Newton-Agham program that aims to establish a diabetic retinopathy screening program (DRSP) in the country.

“The REACH-DR project is responsible for the first validated use of artificial intelligence in the field of ophthalmology in the Philippines, where both researchers work on retinal imaging,” de la Peña said.

A validated artificial intelligence (AI) algorithm for diabetic retinopathy screening was successfully deployed in September this year, marking the first use of AI in ophthalmology in the country.

On Sept. 21, the REACH-DR team with the use of AI successfully performed and completed diabetic retinopathy screening in a target community in Nueva Ecija to identify diabetic retinopathy and other vision-threatening retinal diseases.

READ MORE: https://mb.com.ph/2021/09/30/milestone-dost-study-marks-first-use-of-ai-for-ophthalmology-in-ph/

“Together with the Queen’s University of Belfast of the United Kingdom (UK), the Philippine Eye Research Institute (PERI) leads the program which aims to establish a diabetic retinopathy screening program (DRSP) in the country for a timely diagnosis of those at risk for diabetes-related blindness and vision loss,” de la Peña said.

The DOST-PCHRD said retinal screening is being conducted among underserved communities in Metro Manila and Central Luzon. The REACH-DR team is expected to complete the screening by June 2022.

The project is funded under the Newton Agham Program of the DOST-PCHRD and the UK Medical Research Council, it said.

Related Tags

Fortunato de la Peña PCHRD DOST International Agency for the Prevention of Blindness Eye Health Heroes Award
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.